AAPS PharmSci 360 Annual Meeting will be held November 3-6, 2019 at the Henry Gonzalez Convention Center in San Antonio, TX. The annual meeting focuses on drug development and delivery, manufacturing and packaging, and offers themed programming focused on new technologies, emerging partnership models, and advanced therapeutics.

The exhibition features more than 450 companies offering contract development, manufacturing and packaging services, as well as supplies, and equipment across the drug development continuum. PharmSci 360 attracts more than 7,000 attendees from around the world.

This year’s educational sessions will be broken down into the following five tracks, which will be split equally between chemical and biomolecule areas, resulting in 10 sub-tracks that will cover pharmaceutical sciences most relevant topics.
 
·      Preclinical Development
·      Bioanalytics
·      Clinical Pharmacology
·      Manufacturing and Bioprocessing 
·      Formulation and Quality
 
Preclinical Development will address how preclinical data (e.g. ADME, biology, pharmaceutics, and toxicology) is used to enable compound selection, and making the best use of preclinical models, tools, and data to advance the development of small or large molecules with a high probability of success.
 
Bioanalytics will explore novel therapeutic modalities being developed that use new approaches for molecular interactions and new mechanisms to overcome delivery barriers. These new modalities such as cell therapies, viral gene therapies or next generations of multi-specific antibodies, present various bioanalytical challenges. These sessions will focus on the challenges bioanalytical scientists face and possible solutions during drug development.
 
Clinical Pharmacology will cover advances in drug absorption and disposition during drug development and the modeling and simulation tools and techniques for predicting and assessing systemic and tissue concentration-time profiles, which can provide a valuable resource to support decisions at various stages of the drug development process, regulatory interactions, and personalized treatment of patients.

Manufacturing and Bioprocessing will discuss Process Controls, Manufacturing & Engineering Challenges and Related Strategies. The quality requirements of manufacturing processes and materials characterization are increasing, and through computer modeling, process development, process transfers, and process adjustments can be made smarter and more predictable, if verification or validation succeeds.
 
Formulation and Quality will cover areas of business development evaluations, regulatory, non-clinical assessments, out-licensing preparation, and technical considerations in CMC.

Exhibit Hall Hours
Monday, November 5, 8:30 a.m. – 5:00 p.m.
Tuesday, November 6, 8:30 a.m. – 5:00 p.m.
Wednesday, November 7, 8:30 a.m. – 1:30 p.m.
 
For more information visit: www.aaps.org/pharmsci/annual-meeting